Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Pediatrics Reports
Published in: Current Pediatrics Reports 4/2023

01-12-2023

Eosinophilic Esophagitis, Then and Now: A Review

Author: Roopali Mittal

Published in: Current Pediatrics Reports | Issue 4/2023

Login to get access

Abstract

Purpose of Review

In this review, we highlight new advances in diagnostic and therapeutic modalities of eosinophilic esophagitis (EoE) and progress in understanding of its pathophysiology which has led to these advances.

Recent Findings

The new pharmacological and nonpharmacological treatment options have also focused on improving adherence to the treatment. It has made it possible to treat some more resistant pediatric patients with EoE.

Summary

EoE is the result of esophageal dysfunction secondary to inflammatory/immune response of esophagus to certain antigens present in food or environment, which may be known or unknown. Treatment modalities are directed towards elimination of inciting antigen in the form of dietary eliminations, medications with anti-inflammatory or immunomodulatory effects. Recent research data has supported some new dietary approaches and medication for better response to treatment and improved treatment outcome.
Literature
1.
Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128:3.PubMedCrossRef
2.
Furuta GT. Eosinophils in the esophagus: acid is not the only cause. J Pediatr Gastroenterol Nutr. 1998;26:468.PubMedCrossRef
3.
Ahmad M, Soetikno RM, Ahmed A. The differential diagnosis of eosinophilic esophagitis. J Clin Gastroenterol. 2000;30:242.PubMedCrossRef
4.
Winter HS, Madara JL, Stafford RJ, et al. Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology. 1982;83:818.PubMedCrossRef
5.
6.
7.
8.
Vazquez-Elizondo G, Ngamruengphong S, Khrisna M, et al. The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor. Aliment Pharmacol Ther. 2013;38:1312.PubMedCrossRef
9.
Franciosi JP, Tam V, Liacouras CA, Spergel JM. A case-control study of sociodemographic and geographic characteristics of 335 children with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2009;7:415.PubMedCrossRef
10.
Brusilovsky M, Bao R, Rochman M, et al. Host-microbiota interactions in the esophagus during homeostasis and allergic inflammation. Gastroenterology. 2022;162:521.PubMedCrossRef
11.
Witmer CP, Susi A, Min SB, Nylund CM. Early infant risk factors for pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2018;67:610.PubMedCrossRef
12.
Spergel JM, Book WM, Mays E, et al. Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States. J Pediatr Gastroenterol Nutr. 2011;52:300.PubMedPubMedCentralCrossRef
13.
Shah SC, Tepler A, Peek RM Jr, et al. Association between helicobacter pylori exposure and decreased odds of eosinophilic esophagitis- a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2019;17:2185.PubMedPubMedCentralCrossRef
14.
Bischoff S, Crowe SE. Gastrointestinal food allergy: new insights into pathophysiology and clinical perspectives. Gastroenterology. 2005;128:1089.PubMedCrossRef
15.
Straumann A, Bauer M, Fischer B, et al. Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol. 2001;108:954.PubMedCrossRef
16.
Zhang S, Shoda T, Aceves SS, et al. Mast cell-pain connection in eosinophilic esophagitis. Allergy. 2022;77:1895.PubMedCrossRef
17.
Saffari H, Hoffman LH, Peterson KA, et al. Electron microscopy elucidates eosinophil degranulation patterns in patients with eosinophilic esophagitis. J Allergy Clin Immunol. 2014;133:1728.PubMedCrossRef
18.
19.
20.
Zhu X, Wang M, Mavi P, et al. Interleukin-15 expression is increased in human eosinophilic esophagitis and mediates pathogenesis in mice. Gastroenterology. 2010;139:182.PubMedCrossRef
21.••
Hirano I, Dellon ES, Hamilton JD, et al. Efficacy of dupilumab in a phase 2 randomized trial of adults with active eosinophilic esophagitis. Gastroenterology. 2020;158:111. Dupilumab is effective in the treatment of allergic, atopic, and type 2 inflammatory diseases, and was also found to be effective and safe in the treatment of eosinophilic esophagitis.PubMedCrossRef
22.
Mishra A, Wang M, Pemmaraju VR, et al. Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology. 2008;134:204.PubMedCrossRef
23.
Woodruff SA, Masterson JC, Fillon S, et al. Role of eosinophils in inflammatory bowel and gastrointestinal diseases. J Pediatr Gastroenterol Nutr. 2011;52:650.PubMedCrossRef
24.
Fox VL, Nurko S, Furuta GT. Eosinophilic esophagitis: it’s not just kid’s stuff. Gastrointest Endosc. 2002;56:260.PubMedCrossRef
25.
Wen T, Aronow BJ, Rochman Y, et al. Single-cell RNA sequencing identifies inflammatory tissue T cells in eosinophilic esophagitis. J Clin Invest. 2019;129:2014.PubMedPubMedCentralCrossRef
26.
Almansa C, Krishna M, Buchner AM, et al. Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults. Am J Gastroenterol. 2009;104:828.PubMedCrossRef
27.
Antico A, Fante R. Esophageal hypereosinophilia induced by grass sublingual immunotherapy. J Allergy Clin Immunol. 2014;133:1482.PubMedCrossRef
28.
Lucendo AJ, Arias A, Tenias JM. Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis. Ann Allergy Asthma Immunol. 2014;113:624.PubMedCrossRef
29.
Alexander ES, Martin LJ, Collins MH, et al. Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis. J Allergy Clin Immunol. 2014;134:1084.PubMedPubMedCentralCrossRef
30.
Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol. 2004;113:11.PubMedCrossRef
31.
Spergel JM, Brown-Whitehorn TF, Beausoleil JL, et al. 14 years of eosinophilic esophagitis: clinical features and prognosis. J Pediatr Gastroenterol Nutr. 2009;48:30.PubMedCrossRef
32.
Hill DA, Dudley JW, Spergel JM. The prevalence of eosinophilic esophagitis in pediatric patients with IgE-mediated food allergy. J Allergy Clin Immunol Pract. 2017;5:369.PubMedCrossRef
33.
Remedios M, Campbell C, Jones DM, Kerlin P. Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate. Gastrointest Endosc. 2006;63:3.PubMedCrossRef
34.
Munoz-Osores E, Maldonado-Campos I, Olivares-Labbe MT, et al. Corticosteroids for eosinophilic esophagitis in children: a meta-analysis. Pediatrics. 2020;146
35.
Limketkai BN, Shah SC, Hirano I, et al. Epidemiology and implications of concurrent diagnosis of eosinophilic oesophagitis and IBD based on a prospective population-based analysis. Gut. 2019;68:2152.PubMedCrossRef
36.
Abonia JP, Wen T, Stucke EM, et al. High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders. J Allergy Clin Immunol. 2013;132:378.PubMedCrossRef
37.
Zimmermann D, Criblez DH, Dellon ES, et al. Acute herpes simplex viral esophagitis occurring in 5 immunocompetent individuals with eosinophilic esophagitis. ACG Case Rep J. 2016;3:165.PubMedPubMedCentralCrossRef
38.
Nurko S, Teitelbaum JE, Husain K, et al. Association of Schatzki ring with eosinophilic esophagitis in children. J Pediatr Gastroenterol Nutr. 2004;38:436.PubMedCrossRef
39.
40.
García-Compeán D, González González JA, Marrufo García CA, et al. Prevalence of eosinophilic esophagitis in patients with refractory gastroesophageal reflux disease symptoms: a prospective study. Dig Liver Dis. 2011;43:204.PubMedCrossRef
41.
Mackenzie SH, Go M, Chadwick B, et al. Eosinophilic oesophagitis in patients presenting with dysphagia--a prospective analysis. Aliment Pharmacol Ther. 2008;28:1140.PubMedCrossRef
42.
Kidambi T, Toto E, Ho N, et al. Temporal trends in the relative prevalence of dysphagia etiologies from 1999-2009. World J Gastroenterol. 2012;18:4335.PubMedPubMedCentralCrossRef
43.
Bohm M, Richter JE, Kelsen S, Thomas R. Esophageal dilation: simple and effective treatment for adults with eosinophilic esophagitis and esophageal rings and narrowing. Dis Esophagus. 2010;23:377.PubMed
44.
Gisa M, Laserra G, Marabotto E, et al. Achalasia and obstructive motor disorders are not uncommon in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2021;19:1554.CrossRef
45.
Fox VL, Nurko S, Teitelbaum JE, et al. High-resolution EUS in children with eosinophilic “allergic” esophagitis. Gastrointest Endosc. 2003;57:30.PubMedCrossRef
46.
Roman S, Hirano I, Kwiatek MA, Gonsalves N, Chen J, Kahrilas PJ, Pandolfino JE. Manometric features of eosinophilic esophagitis in esophageal pressure topography. Neurogastroenterol Motil. 2011;23(208–214):e111.PubMed
47.
Sá CC, Kishi HS, Silva-Werneck AL, et al. Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor. Clinics (Sao Paulo). 2011;66:557.PubMedPubMedCentralCrossRef
48.
Safroneeva E, Straumann A, Coslovsky M, et al. Symptoms have modest accuracy in detecting endoscopic and histologic remission in adults with eosinophilic esophagitis. Gastroenterology. 2016;150:581.PubMedCrossRef
49.
Dellon ES, Liacouras CA, Molina-Infante J, et al. Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE Conference. Gastroenterology. 2018;155:1022.PubMedCrossRef
50.
Dellon ES, Gonsalves N, Hirano I, et al. ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013;108:679.PubMedCrossRef
51.
Collins MH. Histopathologic features of eosinophilic esophagitis. Gastrointest Endosc Clin N Am. 2008;18:59.PubMedCrossRef
52.
Lee S, de Boer WB, Naran A, et al. More than just counting eosinophils: proximal oesophageal involvement and subepithelial sclerosis are major diagnostic criteria for eosinophilic oesophagitis. J Clin Pathol. 2010;63:644.PubMedCrossRef
53.
Vicario M, Blanchard C, Stringer KF, et al. Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis. Gut. 2010;59:12.PubMedCrossRef
54.
Nelson MJ, Miller FH, Moy N, et al. Comparison of endoscopy and radiographic imaging for detection of esophageal inflammation and remodeling in adults with eosinophilic esophagitis. Gastrointest Endosc. 2018;87:962.PubMedCrossRef
55.
Erwin EA, James HR, Gutekunst HM, et al. Serum IgE measurement and detection of food allergy in pediatric patients with eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2010;104:496.PubMedPubMedCentralCrossRef
56.
Dellon ES, Gibbs WB, Fritchie KJ, et al. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2009;7:1305.PubMedPubMedCentralCrossRef
57.
Dellon ES, Aderoju A, Woosley JT, et al. Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review. Am J Gastroenterol. 2007;102:2300.PubMedCrossRef
58.
Shoda T, Wen T, Aceves SS, et al. Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study. Lancet Gastroenterol Hepatol. 2018;3:477.PubMedPubMedCentralCrossRef
59.
Carlson DA. Editorial: Widening the use of the functional lumen imaging probe to kids with eosinophilic esophagitis: esophageal narrowing is not just an adult problem. Am J Gastroenterol. 2017;112:1474.PubMedCrossRef
60.
Dalby K, Nielsen RG, Kruse-Andersen S, et al. Gastroesophageal reflux disease and eosinophilic esophagitis in infants and children. A study of esophageal pH, multiple intraluminal impedance and endoscopic ultrasound. Scand J Gastroenterol. 2010;45:1029.PubMedCrossRef
61.
Nicodème F, Hirano I, Chen J, et al. Esophageal distensibility as a measure of disease severity in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2013;11:1101.PubMedPubMedCentralCrossRef
62.
Patel DA, Higginbotham T, Slaughter JC, et al. Development and validation of a mucosal impedance contour analysis system to distinguish esophageal disorders. Gastroenterology. 2019;156:1617.PubMedCrossRef
63.
Moawad FJ, Maydonovitch CL, Veerappan GR, et al. Esophageal motor disorders in adults with eosinophilic esophagitis. Dig Dis Sci. 2011;56:1427.PubMedCrossRef
64.
Januszewicz W, Tan WK, Lehovsky K, et al. Safety and acceptability of esophageal cytosponge cell collection device in a pooled analysis of data from individual patients. Clin Gastroenterol Hepatol. 2019;17:647.PubMedCrossRef
65.
Boyce JA, Assa'a A, Burks AW, et al. Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel Report. Nutrition. 2011;27:253.PubMedCrossRef
66.
Dellon ES, Guo R, McGee SJ, et al. A novel allergen-specific immune signature-directed approach to dietary elimination in eosinophilic esophagitis. Clin Transl Gastroenterol. 2019;10:e00099.PubMedPubMedCentralCrossRef
67.
Alsalamah M, Makhajia M, Somers G, et al. Anaphylaxis to milk after elimination diet for eosinophilic gastrointestinal disease. Am J Gastroenterol. 2016;111:752.PubMedCrossRef
68.
van Rhijn BD, Vlieg-Boerstra BJ, Versteeg SA, et al. Evaluation of allergen-microarray-guided dietary intervention as treatment of eosinophilic esophagitis. J Allergy Clin Immunol. 2015;136:1095.PubMedCrossRef
69.
Spergel JM, Brown-Whitehorn TF, Cianferoni A, et al. Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet. J Allergy Clin Immunol. 2012;130:461.PubMedCrossRef
70.
Spergel JM, Andrews T, Brown-Whitehorn TF, et al. Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann Allergy Asthma Immunol. 2005;95:336.PubMedCrossRef
71.
Ram G, Lee J, Ott M, et al. Seasonal exacerbation of esophageal eosinophilia in children with eosinophilic esophagitis and allergic rhinitis. Ann Allergy Asthma Immunol. 2015;115:224.PubMedCrossRef
72.
Katzka DA. Eosinophilic esophagitis and proton pump-responsive esophageal eosinophilia: what is in a name? Clin Gastroenterol Hepatol. 2014;12:2023.PubMedCrossRef
73.
74.
Protheroe C, Woodruff SA, de Petris G, et al. A novel histologic scoring system to evaluate mucosal biopsies from patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2009;7:749.PubMedPubMedCentralCrossRef
75.
Sayej WN, Patel R, Baker RD, et al. Treatment with high-dose proton pump inhibitors helps distinguish eosinophilic esophagitis from noneosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2009;49:393.PubMedCrossRef
76.
Aceves SS, Newbury RO, Dohil R, et al. Distinguishing eosinophilic esophagitis in pediatric patients: clinical, endoscopic, and histologic features of an emerging disorder. J Clin Gastroenterol. 2007;41:252.PubMedCrossRef
77.
Steiner SJ, Kernek KM, Fitzgerald JF. Severity of basal cell hyperplasia differs in reflux versus eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2006;42:506.PubMedCrossRef
78.
Dellon ES, Chen X, Miller CR, et al. Tryptase staining of mast cells may differentiate eosinophilic esophagitis from gastroesophageal reflux disease. Am J Gastroenterol. 2011;106:264.PubMedCrossRef
79.
Sridhara S, Ravi K, Smyrk TC, et al. Increased numbers of eosinophils, rather than only etiology, predict histologic changes in patients with esophageal eosinophilia. Clin Gastroenterol Hepatol. 2012;10:735.PubMedCrossRef
80.
Lieberman JA, Morotti RA, Konstantinou GN, et al. Dietary therapy can reverse esophageal subepithelial fibrosis in patients with eosinophilic esophagitis: a historical cohort. Allergy. 2012;67:1299.PubMedCrossRef
81.
Reed CC, Safta AM, Qasem S, et al. Combined and alternating topical steroids and food elimination diet for the treatment of eosinophilic esophagitis. Dig Dis Sci. 2018;63:2381.PubMedPubMedCentralCrossRef
82.
Abu-Sultaneh SM, Durst P, Maynard V, Elitsur Y. Fluticasone and food allergen elimination reverse sub-epithelial fibrosis in children with eosinophilic esophagitis. Dig Dis Sci. 2011;56:97.PubMedCrossRef
83.
Wolf WA, Jerath MR, Sperry SL, et al. Dietary elimination therapy is an effective option for adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2014;12:1272.PubMedPubMedCentralCrossRef
84.
Molina-Infante J, Arias Á, Alcedo J, et al. Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: The 2-4-6 study. J Allergy Clin Immunol. 2018;141:1365.PubMedCrossRef
85.
Hoofien A, Dias JA, Malamisura M, Rea F, Chong S, Oudshoorn J, Nijenhuis-Hendriks D, Otte S, Papadopoulou A, Romano C, Gottrand F, Miravet VV, Orel R, Oliva S, Junquera CG, Załęski A, Urbonas V, Garcia-Puig R, Gomez MJM, et al. Pediatric eosinophilic esophagitis: results of the European Retrospective Pediatric Eosinophilic Esophagitis Registry (RetroPEER). J Pediatr Gastroenterol Nutr. 2019;68(4):552–8. https://​doi.​org/​10.​1097/​MPG.​0000000000002215​.CrossRefPubMed
86.
Rank MA, Sharaf RN, Furuta GT, et al. Technical review on the management of eosinophilic esophagitis: a report from the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters. Gastroenterology. 2020;158:1789.PubMedCrossRef
87.••
Kliewer KL, Gonsalves N, Dellon ES, et al. One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial. Lancet Gastroenterol Hepatol. 2023;8:408. This knowledge can improve adherence and better treatment outcome in patients where multiple foods restriction are not needed and comparable results can be obtained with single food restriction.PubMedCrossRef
88.
Klinnert MD. Psychological impact of eosinophilic esophagitis on children and families. Immunol Allergy Clin North Am. 2009;29:99.PubMedCrossRef
89.
Arnim UV, Biedermann L, Aceves SS, et al. Monitoring patients with eosinophilic esophagitis in routine clinical practice - international expert recommendations. Clin Gastroenterol Hepatol. 2022;
90.
Laserna-Mendieta EJ, Casabona S, Guagnozzi D, et al. Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry. Aliment Pharmacol Ther. 2020;52:798.PubMedCrossRef
91.
Wolf WA, Cotton CC, Green DJ, et al. Predictors of response to steroid therapy for eosinophilic esophagitis and treatment of steroid-refractory patients. Clin Gastroenterol Hepatol. 2015;13:452.PubMedCrossRef
92.
Dohil R, Newbury R, Fox L, et al. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. Gastroenterology. 2010;139:418.PubMedCrossRef
93.
Hirano I, Collins MH, Katzka DA, et al. Budesonide oral suspension improves outcomes in patients with eosinophilic esophagitis: results from a phase 3 trial. Clin Gastroenterol Hepatol. 2022;20:525.PubMedCrossRef
94.
Dellon ES, Woosley JT, Arrington A, et al. Efficacy of budesonide vs fluticasone for initial treatment of eosinophilic esophagitis in a randomized controlled trial. Gastroenterology. 2019;157:65.PubMedCrossRef
95.
Noel RJ, Putnam PE, Collins MH, et al. Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2004;2:568.PubMedCrossRef
96.
Lindberg GM, Van Eldik R, Saboorian MH. A case of herpes esophagitis after fluticasone propionate for eosinophilic esophagitis. Nat Clin Pract Gastroenterol Hepatol. 2008;5:527.PubMedCrossRef
97.
Dellon ES, Woosley JT, Arrington A, et al. Rapid recurrence of eosinophilic esophagitis activity after successful treatment in the observation phase of a randomized, double-blind, double-dummy trial. Clin Gastroenterol Hepatol. 2020;18:1483.PubMedCrossRef
98.••
Dupilumab. US Food & Drug Administration (FDA) approved product information. US Food & Drug Administration. Revised May 2022. Dupilumab is useful in non-responders, and in EoE patients with other atopic conditions like asthma/eczema.
99.
Bridgewood C, Wittmann M, Macleod T, et al. T Helper 2 IL-4/IL-13 Dual blockade with dupilumab is linked to some emergent T helper 17–type diseases, including seronegative arthritis and enthesitis/enthesopathy, but not to humoral autoimmune diseases. J Invest Dermatol. 2022;142:2660.PubMedCrossRef
100.
Jung KW, Gundersen N, Kopacova J, et al. Occurrence of and risk factors for complications after endoscopic dilation in eosinophilic esophagitis. Gastrointest Endosc. 2011;73:15.PubMedCrossRef
101.
Richter JE. Esophageal dilation in eosinophilic esophagitis. Best Pract Res Clin Gastroenterol. 2015;29:815.PubMedCrossRef
102.
Stewart MJ, Shaffer E, Urbanski SJ, et al. The association between celiac disease and eosinophilic esophagitis in children and adults. BMC Gastroenterol. 2013;13:96.PubMedPubMedCentralCrossRef
103.
Metadata
Title
Eosinophilic Esophagitis, Then and Now: A Review
Author
Roopali Mittal
Publication date
01-12-2023
Publisher
Springer US
Published in
Current Pediatrics Reports / Issue 4/2023
Electronic ISSN: 2167-4841
DOI
https://doi.org/10.1007/s40124-023-00309-z

Other articles of this Issue 4/2023

Current Pediatrics Reports 4/2023 Go to the issue

ReviewPaper

Review of the Literature on the Intersection of LGBTQ Youth and CSEC: More Than a Monolith

ReviewPaper

New Hormonal Contraceptives and New Roles for Established Hormonal Contraceptives

ReviewPaper

Human Trafficking of Adolescents: A Caribbean Perspective

Invited Commentary

COVID and Children: Where Do We Go from Here?

ReviewPaper

The Care of Transgender and Gender Diverse Adolescents with Eating Disorders

ReviewPaper

The Aetiology and Global Impact of Paediatric Sepsis